✦ LIBER ✦

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

✍ Scribed by Denham, James W; Joseph, David; Lamb, David S; Spry, Nigel A; Duchesne, Gillian; Matthews, John; Atkinson, Chris; Tai, Keen-Hun; Christie, David; Kenny, Lizbeth; Turner, Sandra; Gogna, Nirdosh Kumar; Diamond, Terry; Delahunt, Brett; Oldmeadow, Christopher; Attia, John; Steigler, Allison

Book ID: 126612112
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 542 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70328-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life in men with locally adva

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

✍ James W Denham; Chantelle Wilcox; David Joseph; Nigel A Spry; David S Lamb; Keen 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 309 KB

Adding androgen suppression to radiother

Adding androgen suppression to radiotherapy may improve disease-free survival over radiotherapy alone in locally advanced prostate cancer: Abstracted from: Bolla M, Collette L, Blank L et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002; 360: 103–6.

✍ John B Fiveash 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB